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Abstract
Background: Suppurative otitis media (SOM) is a major public health concern worldwide and is associated with
increased morbidity. Cases of fungal suppurative otitis media were studied to establish the effect of fungi in otitis
media.
Methods: Ear swabs from 410 patients were collected aseptically using sterile cotton swabs from discharging ear
through perforated tympanic membrane. Swabs were subjected to microscopic and culture investigations. The
species of fungal growing on Sabouraud’s agar were identified using MALDI-TOF MS. For moulds broth micro
dilution method following EUCAST guidelines was employed to determine susceptibility patterns against
itraconazole, voriconazole and posaconazole.
Results: A total of 44 (10.74 %) cases with positive fungal culture growth were studied. The median age of patients
with fungal infection was 29.5 (IQR 16–43) years. Of 44 patients; 35 (79.6 %) had pure growth of one type of fungal.
Candida albicans was the most common fungus isolated (n = 13; 29.6 %) followed by Aspergillus versicolor (n = 8; 18.2 %).
A total of 7 (15.9 %) patients had disease complication at time of enrollment; of them 6 (13.6 %) had hearing loss. On
follow up 7 (15.9 %) had poor treatment outcome. All five Aspergillus fumigatus strains resistant itraconazole with
reduced susceptibility to voriconazole and posaconazole carried carrying TR34/L98H resistance allele. In addition, all
Penicillium citrinum isolates were resistant to voriconazole while all Penicillium sumatrense were resistant to both
itraconazole and voriconazole. There were non-significant association of poor treatment outcome and female gender,
being HIV positive and being infected with moulds.
Conclusion: Fungal infections play a significant role in SOM pathology in our setting. Diagnosis of fungal infections in
developing countries should be improved so that appropriate management can be initiated on time to prevent
associated complications.
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Background
Suppurative otitis media (SOM) is characterized by the
inflammation of the middle ear and mastoid, tympanic
membrane perforation as well as discharge [1]. The tym-
panic membrane perforation may result in increased expos-
ure of the middle ear to pathogens [2, 3]. In developing
countries, SOM is a major cause of preventable hearing loss
[4–6], its incidence ranges from 7 to 46 % and is common
amongst children of lower socio-economic status [7, 8]. In
Tanzania, SOM constitutes a major cause of otorhinolaryn-
gology clinic visits and contributes significantly to high
morbidity and long term hearing loss [9–11]. While bacter-
ial pathogens (most prominently Pseudomonas aeruginosa
and Staphylococcus aureus [12–15]) have commonly been
documented as the cause of SOM in developing countries,
the role of fungal infections among patients with SOM is
still underestimated [3, 16, 17]. Fungal infections among
patients with SOM account for 2.1–25 % of cases [12–14]
and Aspergillus spp. are the commonest cause accounting
for 92.1 % of cases [12, 18].
Fungal infections are mainly attributed by compromised
immune status, prolonged antibiotic use and immune sup-
pressive therapy [19, 20]. This aspect of mycosis has gained
importance over the recent years because of the excessive
use of broad-spectrum antibiotics, and an increase in the
number of immunodeficiency conditions such as immuno-
globulin deficiency, malignant neoplasms, immunosuppres-
sive therapy (corticosteroids and cytotoxic chemotherapy),
diabetic mellitus as well as AIDS [3, 8, 21].
Fungi have been least documented as the cause of SOM
in Africa probably due to lack of laboratory diagnose for
fungal infections in these settings. Here, we determined
the prevalence of fungal occurring in the otolaryngology
clinic and surgical wards of Bugando Medical Centre
(BMC), Mwanza Tanzania complicating cases of SOM.
Methods
Sample collection
A total of 410 patients with suppurative otitis media at-
tending at BMC otorhinolaryngology clinic in a period
of three months were investigated. For each patient with
suppurative otitis media, ear swabs were aseptically
collected using sterile cotton swabs (Heinz Herenz
Hamburg, Germany).
Microbiology
Swabs were transported to microbiology laboratory using
Stuart transport media (HiMedia, India) and subjected to
microscopic investigation by Gram’s stain as well as culture
on sheep blood (BA), Mackonkey (MCA) and sabouraud’s
dextrose agar supplemented with 50 mg/ml gentamicin and
50 mg/ml chloramphenicol (SDA) (Oxoid, UK). Plates were
aerobically incubated at 35 °C for 24–48 h. Fungal cultures
with at least 2+ growth were considered as significant [22].
Significant positive fungal pathogens on the SDA were fur-
ther characterized while all other organisms were subjected
to the normal procedures according to the BMC microbiol-
ogy laboratory (Southern African Development Community
Accreditation Service (SADCAS) with a unique number
MED 002) standard operating procedures.
Growth on SDA plates was preliminary classified as
mould or yeast based on the colony color and morph-
ology. Yeast isolates were identified as growth of creamy
to white colonies while moulds were identified as the fila-
mentous colonies of various appearances [23]. CHROM
agar (OXOID, England) was used as previously described
for preliminary identifications of yeast in case of mixed
growth [23].
Species identification was done by matrix-assisted laser
desorption ionization-time of flight (MALDI-TOF) mass
spectrometry (Bruker Daltonics, Bremen, Germany) on ex-
tracted cells harvested from agar plates (yeasts) or from
overnight shaking cultures (moulds) in sabouraud’s broth
(Oxoid, Wesel, Germany) as previous described [24, 25].
All moulds isolated were subjected to antimicrobial
susceptibility testing using broth micro-dilution method ac-
cording to EUCAST guidelines [26]. The antifungal agents
tested were itraconazole, voriconazole (Discovery Fine Che-
micals, Bournemouth, United Kingdom) and posaconazole
(MSD Sharp and Dohme, Haar, Germany). Plates were in-
cubated at 37 °C for 48 h and MIC values for all drugs were
visually determined as the lowest concentrations with no
visible growth.
For azole resistant A. fumigatus isolates, the cyp51A
locus was amplified by PCR and the resulting fragments
sequenced as described before [27].
All patients were managed according to the standard
protocol at BMC. All patients were initially treated conser-
vatively, including aural toilet and applications of appro-
priate antibiotics as per bacterial culture and sensitivity
results [15]. Whenever fungal infections were suspected,
patients were treated empirically; this included removal of
fungal debris and application of boric acid or combina-
tions of antibiotics and antifungals. In the current study,
poor treatment outcome was defined as persistence of
otorrhea while the treatment success was defined as the
disappearance of the signs and symptoms after 14 weeks
follow-up [15].
Results
Out of 410 patients with SOM, 44 (10.7 %, 95 % CI 7.7–
13.7) had significant fungal growth. The studied cases are
summarized in Table 1. The median age (inter quartile
range (IQR) of patients with fungal infections was 29.5
(IQR 16–43) years. Male formed majority of patients with
fungal infections (n = 24, 54.6 %). The median duration of
illness was 18 (IQR 5–24) weeks. Of the 44 patients with
fungal infections, 6 (13.6 %) were HIV positive. On Mann
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Table 1 Summary of 44 cases of SOM with fungal infection
ID aDuration (weeks) HIV Isolates Complication Treatment outcome
ES025 60 Neg A. flavus Hearing loss Not Cured
ES036 60 Neg A. flavus None Cured
ES091 70 Neg A. flavus None Cured
ES093 12 Neg A. flavus None Cured
ES193 8 Neg A. flavus, A. versicolor None Not Cured
ES026 4 Neg A. fumigatus None Cured
ES028 32 Neg A. fumigatus None Cured
ES095 20 Neg A. fumigatus None Cured
ES027 90 Pos A. fumigatus, A. flavus None Cured
ES057 18 Neg A. sydowii, P. chrysogenum Mastoditis Cured
ES117 18 Neg A. versicolor None Cured
ES130 32 Neg A. versicolor Hearing loss Cured
ES143 18 Neg A. versicolor Hearing loss Cured
ES179 18 Neg A. versicolor None Cured
ES195 15 Neg A. versicolor, A. sydowii, P. sumatrense Hearing loss Cured
ES112 24 Neg A. versicolor, P. citrinum None Not Cured
ES001 24 Neg C. albicans None Cured
ES002 12 Neg C. albicans None Cured
ES016 2 Neg C. albicans None Cured
ES030 12 Neg C. albicans None Cured
ES032 48 Neg C. albicans Hearing loss Not Cured
ES033 24 Neg C. albicans None Cured
ES048 4 Neg C. albicans None Cured
ES063 10 Neg C. albicans None Cured
ES064 1 Neg C. albicans None Cured
ES065 4 Pos C. albicans None Cured
ES083 1 Neg C. albicans None Cured
ES185 13 Neg C. albicans None Cured
ES097 20 Neg C. albicans None Cured
ES031 24 Neg C. parapsilosis Hearing loss Not Cured
ES035 0.5 Neg C. parapsilosis None Cured
ES061 6 Neg C. parapsilosis None Cured
ES019 1 Pos C. tropicalis None Cured
ES020 1 Pos C. tropicalis None Cured
ES037 1 Neg C. tropicalis None Cured
ES052 72 Neg C. tropicalis None Cured
ES058 20 Neg C. tropicalis None Cured
ES005 3 Neg C. tropicalis, A. fumigatus None Cured
ES175 9 Pos P. chrysogenum None Cured
ES077 18 Neg P. citrinum None Cured
ES125 48 Pos P. citrinum None Not Cured
ES085 6 Neg P. citrinum, A. versicolor None Not Cured
ES132 24 Neg P. citrinum, P. lilacinus None Cured
ES149 18 Neg P. sumatrense, A. versicolor None Cured
aDuration indicate the period the patients has stayed with otitis media before presenting at otolaryngology clinic of BMC
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Whitney ranksum test, there were non-significant differ-
ence in the median duration of illness between patients
with fungal infections and those without fungal infections
(18, IQR: 5–24 vs. 12 IQR: 5–24, p = 0.5749).
Out of the 44 positive fungal cultures, 35 (79.6 %) pro-
duced pure growth of only one fungal species, while nine
(20.4 %) had mixed fungal growth. A total of 23 (52.3 %)
patients were positive for moulds and 21 (47.7 %) positive
for yeast. Candida albicans was the most commonly iso-
lated fungal (n = 13, 29.6 %) followed by Aspergillus versi-
color (n = 8, 18.2 %) (Table1). A total of seven (15.9 %)
patients had disease complication at time of enrollment; of
them six (13.6 %) had hearing loss. On follow up, seven
(15.9 %) had poor treatment outcome. Out of 366 pa-
tients with no fungal growth; 30 (8.2 %) had hearing
loss as compared to 7/44 (15.9 %) of those with fun-
gal infections (p = 0.0339).
All five strains of Aspergillus fumigatus isolates were re-
sistant to itraconazole and showed reduced in vitro suscepti-
bility to both voriconazole and posaconazole. Sequencing of
the cyp51A locus revealed these isolates to carry the TR34/
L98H resistance allele. Penicillium citrinum isolates were re-
sistant to voriconazole and had reduced susceptibility to
itraconazole and posaconazole. All Penicillium sumatrense
were resistant to both itraconazole and voriconazole, and
showed reduced susceptibility to posaconazole (Table 2).
There were non- significant association of the poor
treatment outcome with increase in age, female gender, be-
ing HIV positive and being infected with moulds Table 3.
Discussion
SOM is highly associated with lower social economic
status, potentially due to poor hygiene, low access to
medical care, or lack of knowledge [28]. In the current
study, the majority of patients with positive fungal
growth were from rural area where there are no hospi-
tals with otolaryngology services. Most of these patients
presented in BMC after six months of illness.
As seen in other studies [10], C. albicans and Aspergil-
lus spp. were the most commonly isolated fungal from
SOM specimens. The ability of C. albicans to maintain
the synergistic relationship with bacterial pathogenic
flora of skin like S. aureus and ecological niche of these
isolates may explain the findings [29, 30].
Fungal have mainly been documented as opportunistic
pathogens causing infections in immunocompromised pa-
tients. Among the 44 fungal-infected cases of SOM studied
here, only six (15.9 %) were HIV positive, which increased
the risk of getting poor treatment outcome of SOM by 1.2
fold. The immunocompromised state of these patients
could explain this observation. However, this observation
was not statistically significant. This necessitates the need
to identify other risk factors associated with fungal infec-
tions among HIV-negative individuals in future studies.
In the current study, with eight isolates, A. versicolor
was the predominant Aspergillus species. A. versicolor is
a highly resilient/resistant fungus found in damp indoor
environment, able to produce hepatotoxic and carcino-
genic mycotoxin sterigmatocystin [31, 32].
Patients infected with moulds had 5.5 times higher risk
of getting poor treatment outcome than patients with
Candida infections. This could be explained by the fact
that the majority (in fact all of the A. fumigatus, P. suma-
trense, and P. citrinum isolates) were resistant to at least
one commonly used antifungal agent. For the past two de-
cades the increasing occurrence of A. fumigatus isolates
resistant to common azoles antifungal agents has been de-
scribed, including in Tanzania [33]. In our study, all A.
fumigatus isolates indeed carried the TR34/L98H allele,
which shows that the environmental occurrence of these
isolates is also clinically relevant in Tanzania. Additionally,
Table 2 Antimicrobial susceptibility patterns
ID Species Itraconazole Voriconazole Posaconazole
ES93A Aspergillus flavus 0.5 0.25 0.25
ES05B Aspergillus fumigatus 32 1 0.5
ES026 Aspergillus fumigatus 32 4 1
ES95 Aspergillus fumigatus 32 2 1
ES95 Aspergillus fumigatus 32 1 0.5
ES95 Aspergillus fumigatus 32 2 1
ES57A Aspergillus sydowii 0.5 0.5 0.25
ES95B Aspergillus sydowii 0.5 0.25 0.5
ES85B Aspergillus versicolor 0.25 0.03 0.25
ES93B Aspergillus versicolor 0.13 0.5 0.5
M112A Aspergillus versicolor 0.5 0.25 0.25
M117 Aspergillus versicolor 0.25 0.13 0.5
M130 Aspergillus versicolor 1 0.5 0.5
M143 Aspergillus versicolor 0.5 0.5 0.5
M149A Aspergillus versicolor 0.5 0.25 0.25




ES77 Penicillium citrinum 0.5 16 0.5
ES85A Penicillium citrinum 0.25 8 0.25
ES95A Penicillium citrinum 0.5 16 0.5
M112B Penicillium citrinum 0.5 16 0.25
M125 Penicillium citrinum 0.5 16 0.25
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all isolates of P. citrinum and P. sumatrense were resistant
to the lead antifungal agent itraconazole or showed re-
duced susceptibility to voriconazole. However in these
species the underlying resistance mechanism is unknown.
In most clinical settings in resource-constrained coun-
tries like Tanzania where fungal diagnostics is under-
developed; treatment of fungal infections relies solely on
the empirical use of topical azole agents, which has pre-
viously been reported to be in effective for A. versicolor
[34], the most frequent moulds isolated here and is
probably similarly ineffective for azole-resistant A. fumi-
gatus, a significant emerging problem.
In the current study 15.9 % of patients infected with
fungi developed complications, mostly irrevocable hear-
ing loss, proving that hearing loss is a major complica-
tion developed by patients with suppurative otitis media
[35]. The clinical impact of fungal infections in patients
with SOM should drive the effort to improve fungal
diagnostics in developing countries.
One of the limitations of this study is the possibility of
skin flora contamination during sample collections. How-
ever; the quantification of fungal growth significantly min-
imized the chances suggesting that majority of patients
had real fungal infections.
Conclusion
Fungal infections played a significant role in SOM path-
ology under low resource settings. Diagnosis of fungal in-
fections in developing countries should be improved so
that appropriate management can be initiated on time to
prevent associated complications.
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